Home › NDC Lookup › RxCUI directory › RxCUI 198049

Ofloxacin 300 MG Oral Tablet — RxCUI 198049

RxNorm drug concept · Semantic clinical drug
RxCUI 198049 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 36 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198049
Official nameOfloxacin 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped36
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ofloxacin Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats bacterial eye infections, specifically bacterial conjunctivitis (pink eye) and bacterial corneal ulcers. It only works on infections caused by bacteria that are sensitive...
  • It depends on the infection. Conjunctivitis dosing is every few hours at first, then four times a day. Corneal ulcers need much more frequent dosing at the start, even during the n...
  • The most common is brief burning or discomfort in the eye. Stinging, redness, itching, blurry vision, watery or dry eyes, light sensitivity and eye pain can also happen. These are...
  • Stop the drops and get emergency help if you have trouble breathing, swelling of your face, lips or throat, hives, or feel faint. These can be signs of a serious allergic reaction....
📖 Read our full Ofloxacin Ophthalmic guide →

🕸️ Concept Web — How Ofloxacin 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ofloxacin 300 MG Oral Tablet RxCUI 198049

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ofloxacin 7623
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ofloxacin Oral Tablet 373141
    • Ofloxacin Oral Product 1160452
    • Ofloxacin Pill 1160454
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ofloxacin 300 MG 316401

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ofloxacin 300 MG SCDC · 316401
  • Ofloxacin Oral Tablet SCDF · 373141
  • Ofloxacin Oral Product SCDG · 1160452
  • Ofloxacin Pill SCDG · 1160454

📦 FDA Products & Package NDCs

12 products · 36 package NDCs
36 package NDCs map to RxCUI 198049 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71209-0097-02 50 TABLET, FILM COATED in 1 BOTTLE (71209-097-02) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0097-05 100 TABLET, FILM COATED in 1 BOTTLE (71209-097-05) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0097-10 500 TABLET, FILM COATED in 1 BOTTLE (71209-097-10) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0098-02 50 TABLET, FILM COATED in 1 BOTTLE (71209-098-02) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0098-05 100 TABLET, FILM COATED in 1 BOTTLE (71209-098-05) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0098-10 500 TABLET, FILM COATED in 1 BOTTLE (71209-098-10) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0099-02 100 TABLET, FILM COATED in 1 BOTTLE (71209-099-02) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0099-05 500 TABLET, FILM COATED in 1 BOTTLE (71209-099-05) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
71209-0099-10 50 TABLET, FILM COATED in 1 BOTTLE (71209-099-10) OFLOXACIN Cadila Pharmaceuticals Limited 2015-12-29
72241-0072-02 50 TABLET, FILM COATED in 1 BOTTLE (72241-072-02) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0072-05 100 TABLET, FILM COATED in 1 BOTTLE (72241-072-05) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0072-10 500 TABLET, FILM COATED in 1 BOTTLE (72241-072-10) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0073-02 50 TABLET, FILM COATED in 1 BOTTLE (72241-073-02) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0073-05 100 TABLET, FILM COATED in 1 BOTTLE (72241-073-05) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0073-10 500 TABLET, FILM COATED in 1 BOTTLE (72241-073-10) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0074-02 50 TABLET, FILM COATED in 1 BOTTLE (72241-074-02) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0074-05 100 TABLET, FILM COATED in 1 BOTTLE (72241-074-05) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
72241-0074-10 500 TABLET, FILM COATED in 1 BOTTLE (72241-074-10) OFLOXACIN Modavar Pharmaceuticals LLC 2025-06-24
75834-0112-01 100 TABLET, COATED in 1 BOTTLE (75834-112-01) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0112-05 500 TABLET, COATED in 1 BOTTLE (75834-112-05) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0112-50 50 TABLET, COATED in 1 BOTTLE (75834-112-50) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0119-01 100 TABLET, COATED in 1 BOTTLE (75834-119-01) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0119-05 500 TABLET, COATED in 1 BOTTLE (75834-119-05) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0119-50 50 TABLET, COATED in 1 BOTTLE (75834-119-50) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0120-01 100 TABLET, COATED in 1 BOTTLE (75834-120-01) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0120-05 500 TABLET, COATED in 1 BOTTLE (75834-120-05) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0120-50 50 TABLET, COATED in 1 BOTTLE (75834-120-50) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2016-07-15
75834-0199-01 100 TABLET, COATED in 1 BOTTLE (75834-199-01) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0199-05 500 TABLET, COATED in 1 BOTTLE (75834-199-05) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0199-50 50 TABLET, COATED in 1 BOTTLE (75834-199-50) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0200-01 100 TABLET, COATED in 1 BOTTLE (75834-200-01) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0200-05 500 TABLET, COATED in 1 BOTTLE (75834-200-05) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0200-50 50 TABLET, COATED in 1 BOTTLE (75834-200-50) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0201-01 100 TABLET, COATED in 1 BOTTLE (75834-201-01) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0201-05 500 TABLET, COATED in 1 BOTTLE (75834-201-05) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
75834-0201-50 50 TABLET, COATED in 1 BOTTLE (75834-201-50) OFLOXACIN Nivagen Pharmaceuticals, Inc. 2019-01-25
Observed labelers: Nivagen Pharmaceuticals, Inc. (18) · Cadila Pharmaceuticals Limited (9) · Modavar Pharmaceuticals LLC (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.